OCS (Oculis Holding AG) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OCS Oculis Holding AG OCS
26 GF Score
Price $12.88
! 1 Warning Sign
View Full Analysis

What is Oculis Holding AG Net Loan?

Net Loan only applies to banks and insurance companies.

OCS
26GF Score
Oculis Holding AG OCS
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oculis Holding AG Business Description

Other Exchanges OCS:IcelandCR5:Germany
Address Bahnhofstrasse 20, Zug, CHE, CH-6300
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
26GF Score

Get the complete analysis for OCS

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.88
Price